Hamartoma: Clinical Trials

19 trials for Hamartoma, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed, 5 unknown, 3 recruiting, 2 enrolling by invitation. 19 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable19Completed 6, Unknown 5, Recruiting 3, Enrolling by invitation 2, Withdrawn 2, Active not recruiting 1

Follow Hamartoma: new trials by email Literature Review of Hamartoma trials Research Report on Hamartoma

Trials (filtered) newest first · largest first

All 19 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Smart Phone Application to Improve Adoption of the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease (CKD) Guidelines
Use of an electronic digital Application - Chronic Kidney Disease, Proteinuria
Not applicableRecruitingSt. James's Hospital, Ireland802026-01-142026-05-01
TANDem-2: Closing the Gap to Interventions for TAND
Well-Beans for Caregivers Program - Adult Caregivers of Individuals With TSC, Tuberous Sclerosis Complex (TSC)
Not applicableEnrolling by invitationVrije Universiteit Brussel302025-07-152025-09-22
Video Capsule Examination in Patients With Lynch Syndrome
Video capsule investigation - Lynch Syndrome, Li Fraumeni Syndrome
Not applicableRecruitingRoyal Marsden NHS Foundation Trust252024-03-042024-12-05
Web Intervention for Parents of Youth With Genetic Syndromes (WINGS)
Functional Behavioral Training (FBT), Positive Parenting Strategies-Treatment as Usual - Telomeric 22Q13 Monosomy Syndrome, Tuberous Sclerosis
Not applicableActive not recruitingRush University Medical Center792023-09-152026-09-18
Remote Assessment and Intervention for Behavior Problems in Kids With TSC
Parent-Child Interaction Therapy (PCIT) - Tuberous Sclerosis
Not applicableCompletedUniversity of California, Los Angeles1012022-08-012026-03-18
KidneYou - Innovative Digital Therapy
KidneYou APP - Chronic Kidney Diseases, Diabetes
Not applicableCompletedAdvice Pharma Group srl2102022-07-182024-11-06
Acceptance and Commitment Therapy in Tuberous Sclerosis Complex
Acceptance and Commitment Therapy (ACT) - Tuberous Sclerosis Complex
Not applicableUnknownUniversity Hospitals Bristol and Weston NHS Foundation Trust152021-08-122024-02-14
TSC Remote Assessment and Intervention
JASPER - TSC
Not applicableCompletedUniversity of California, Los Angeles542020-10-312024-10-30
Parent and Infant Inter(X)Action Intervention (PIXI)
Parent-Infant Inter(X)action Intervention (PIXI) - Fragile X Syndrome, Angelman Syndrome
Not applicableEnrolling by invitationRTI International1202018-11-302026-07-13
Response of Immune System to Flu Vaccination in PHTS
Influvac Tetra - PTEN Hamartoma Tumor Syndrome
Not applicableUnknownRadboud University Medical Center302018-10-012018-08-15
Use of a Tonometer to Identify Epileptogenic Lesions During Pediatric Epilepsy Surgery
Intra-operative brain tonometry - Epilepsy, Focal Cortical Dysplasia
Not applicableWithdrawnUniversity of California, Los Angeles2018-07-162023-10-10
Turmeric as Treatment in Epilepsy
Turmeric - Epilepsy, Dravet Syndrome
Not applicableWithdrawnNYU Langone Health2018-03-012018-04-30
JASPER Early Intervention for Tuberous Sclerosis
JASPER - Tuberous Sclerosis
Not applicableUnknownUniversity of California, Los Angeles642017-10-242020-11-06
Characterizing Sleep Disorders in Children and Adults With Tuberous Sclerosis Complex (TSC)
Questionnaires, electroencephalogram (EEG), polysomnography - Sleep Disorder
Not applicableUnknownUniversitair Ziekenhuis Brussel602017-09-272018-10-17
A Feasibility Safety Study of Benign Centrally-Located Intracranial Tumors in Pediatric and Young Adult Subjects
ExAblate 4000 System - Benign Centrally-Located Intracranial Tumors
Not applicableRecruitingInSightec202017-02-282026-06-29
Early Behavioral Intervention to Improve Social Communication Function in Infants With Tuberous Sclerosis Complex
JASPER - Tuberous Sclerosis Complex
Not applicableCompletedUniversity of California, Los Angeles82015-09-012026-07-23
DECODING Study (Dermal Electrochemical Conductance in Diabetic Neuropathy)
dermal electrochemical conductance (DEC), Monofilament testing - Neuropathy, Diabetic, Diabetes Mellitus, Type 2
Not applicableCompletedFundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina1472015-05-012019-02-27
Long-term, Prospective Study Evaluating Clinical and Molecular Biomarkers of Epileptogenesis in a Genetic Model of Epilepsy - Tuberous Sclerosis Complex
epilepsy early diagnosis protocol - TSC, Tuberous Sclerosis Complex
Not applicableUnknownSergiusz Jozwiak1002013-11-012014-04-04
Can Recurrence of Hamartomas be Prevented?
Endobronchial hamartomas treatment - Airway Obstruction, Hamartoma of Lung
Not applicableCompletedAtatürk Chest Diseases and Chest Surgery Training and Research Hospital212012-05-012018-07-30

Narrower conditions

Tuberous Sclerosis (14)  ·  Epilepsy (4)  ·  Hamartoma Syndrome, Multiple (4)  ·  Angelman Syndrome (2)  ·  Fragile X Syndrome (2)  ·  Renal Insufficiency, Chronic (2)  ·  Rett Syndrome (2)  ·  Telomeric 22q13 Monosomy Syndrome (2)  ·  Airway Obstruction (1)  ·  Albuminuria (1)  ·  Autistic Disorder (1)  ·  Brain Neoplasms (1)  ·  Child Development Disorders, Pervasive (1)  ·  Chromosome 15q, partial deletion (1)

Broader conditions

Neoplasms (19)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (17)  ·  Genetic Diseases, Inborn (17)  ·  Neoplasms, Multiple Primary (17)  ·  Neoplastic Syndromes, Hereditary (17)  ·  Nervous System Diseases (15)  ·  Congenital Abnormalities (14)  ·  Heredodegenerative Disorders, Nervous System (14)  ·  Malformations of Cortical Development (14)  ·  Malformations of Cortical Development, Group I (14)  ·  Nervous System Malformations (14)  ·  Neurocutaneous Syndromes (14)  ·  Neurodegenerative Diseases (14)  ·  Central Nervous System Diseases (6)

Interventions

Activator Appliances (3)  ·  Acceptance and Commitment Therapy (1)  ·  Actigraphy (1)  ·  Colonoscopy (1)  ·  Curcumin (1)  ·  Physical Examination (1)  ·  Surveys and Questionnaires (1)

Sponsors

University of California, Los Angeles (5)  ·  Advice Pharma Group srl (1)  ·  Atatürk Chest Diseases and Chest Surgery Training and Research Hospital (1)  ·  Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina (1)  ·  InSightec (1)  ·  NYU Langone Health (1)  ·  RTI International (1)  ·  Radboud University Medical Center (1)  ·  Royal Marsden NHS Foundation Trust (1)  ·  Rush University Medical Center (1)  ·  Sergiusz Jozwiak (1)  ·  St. James's Hospital, Ireland (1)  ·  Universitair Ziekenhuis Brussel (1)  ·  University Hospitals Bristol and Weston NHS Foundation Trust (1)  ·  Vrije Universiteit Brussel (1)

Countries

United States (10)  ·  Belgium (2)  ·  Italy (2)  ·  United Kingdom (2)  ·  Australia (1)  ·  Austria (1)  ·  Canada (1)  ·  Czechia (1)  ·  France (1)  ·  Germany (1)  ·  Ireland (1)  ·  Netherlands (1)  ·  Poland (1)  ·  Spain (1)

Top investigators

Alessandra Pereira,, PhD, MD (1)  ·  Alessandro Flavio Ferri (1)  ·  Anna Jansen, MD, PhD (1)  ·  Anna Jansen, PhD, MD (1)  ·  Anne Wheeler, PhD (1)  ·  Aria Fallah, MD (1)  ·  Bernardo Costa, MD (1)  ·  Donal Sexton, MB BCh BAO BSc, MRCPI, MD, PhD (1)  ·  John Ragheb, MD (1)  ·  Magda Nunes, PhD, MD (1)  ·  Manisha Holmes, MD (1)  ·  Nicole McDonald, PhD (1)  ·  Oliviero Bruni, PhD, MD (1)  ·  Paolo Curatolo, PhD, MD (1)  ·  Petrus J de Vries, MD PhD (1)

Results publications

PMID 19141364, PMID 22113127, PMID 23732715, PMID 27222591, PMID 29797247, PMID 31237569, PMID 31912454, PMID 31969108, PMID 39625912, PMID 41738544, PMID 42085697, PMID 6668417

NIH funding

R01HD090138 (1)